Efficacy and immune modulation of KRAS G12C inhibitor sotorasib in murine KRAS G12C mutant non-small cell lung cancers with major co-occurring genomic alterations

Authors

Teng Zhou, The University of Texas MD Anderson Cancer Center
Minh Truong Do, The University of Texas MD Anderson Cancer Center
Haniel Araujo, The University of Texas MD Anderson Cancer Center
Richard Lee, The University of Texas MD Anderson Cancer Center
Ferdinandos Skoulidis, The University of Texas MD Anderson Cancer Center

Files

Abstract

View full abstract

DOI

https://doi.org/10.52519/00100

Publication Date

2022

Department

Thoracic Head and Neck Medical Oncology

Research Category

Unleashing the Immune System to Develop Therapeutic Strategies

Recommended Citation

Zhou, Teng; Truong Do, Minh; Araujo, Haniel; Lee, Richard; and Skoulidis, Ferdinandos, "Efficacy and immune modulation of KRAS G12C inhibitor sotorasib in murine KRAS G12C mutant non-small cell lung cancers with major co-occurring genomic alterations" (2022). Leading Edge of Cancer Research Symposium. 52.
doi:https://doi.org/10.52519/00100